Pharmaceuticals

1. SONUS Pharmaceuticals - Sonus Pharmaceuticals Presents Preclinical Data on Novel Camptothecin ... Sonus Pharmaceuticals Highlights Corporate Progress and Reports Third ... www.sonuspharma.com Mama
2. The Generic Challenge- Understanding Patents, Fda And Pharmaceutical Life-cycle Management

   The Generic Challenge

   Understanding Patents, Fda And Pharmaceutical Life-cycle Management:
   • Book by Martin A. Voet.
3. National Fish Pharmaceuticals - Manufacturer with bulk sales of pharmaceuticals and chemicals for the tropical fish industry. Product list, and articles about diseases and prevention. www.fishyfarmacy.com Mama
4. Chemicals & Pharmaceuticals Online - health, nutritional & herbal... - Chemicals and pharmaceuticals online provides information health supplements, nutritional & herbal supplements, biochemicals, amino acids, enzyme supplements, ... www.greatvistachemicals.com Mama
5. Forest Pharmaceuticals -- Mary Shomon's Thyroid Drug Database, featuring Thyroid Drugs & Manufa - Forest Pharmaceuticals -- Mary Shomon's Thyroid Drug Database, featuring Thyroid Drugs & Manufacturers, and Information on Drugs Including Synthroid, Levothyroxine, Armour, Cytomel, T3 and Others thyroid.about.com Mama
6. AstraZeneca in the United States - ... others. Legal notice Privacy Statement © 2004 [AstraZeneca]Create? Pharmaceuticals LP Worldwide locations Search Advanced search Site map Quick links Clinical trials information Job opportunities Key products ... www.astrazeneca-us.com Mama
7. Vertex Pharmaceuticals Incorporated - Visit the link for details. www.vpharm.com Mama
8. Welcome to Aquarium Pharmaceuticals! - Copyright Aquarium Pharmaceuticals,Inc. ... www.aquariumpharm.com Mama
9. Pfizer Inc: The world's largest research-based pharmaceutical ... - Discovers, develops, manufactures and markets prescription human and veterinary medicines, and consumer healthcare products. www.pfizer.com Mama
10. Watson Pharmaceuticals Inc. - Visit the link for details. www.watsonpharm.com Mama
11. Pharmaceutical Calculations

    Pharmaceutical Calculations

    • Book by Joel L. Zatz and Maria Glaucia Teixeira.
12. Medis Health and Pharmaceuticals - Canadian based distributor of pharmaceuticals and medical supplies and services. www.medis.ca Mama
13. Forest Pharmaceuticals Recalls Thyrolar - April 2003 - Forest Pharmaceuticals Recalls Thyrolar, April 2003, brought to you by Thyroid Guide and patient advocate Mary Shomon thyroid.about.com Mama
14. Tested Imported Pharmaceuticals: 88% Counterfeit - Tested Imported Pharmaceuticals: 88% Counterfeit headaches.about.com Mama
15. pharmaceuticals, software developers, development, uk - pharmaceuticals, software developers uk, development, microsoft visual basic, sql server and microsoft access database applications Home About Us Company ... www.rand-systems.com Mama
16. Ashok Pharmaceuticals - Manufacturers and exporters of pharmaceuticals. Provides company profile, product list and contact information. www.maxpages.com Mama
17. Drug Information by RxList - Drug Information for Prescription Drugs, Side Effects, Interactions, Warnings, Overdose, Patient Info, Pharmacology, Online Pharmacy... www.rxlist.com Mama
18. Drug InfoNet - Newsfeed - [general] - The Internet source for healthcare information. Provides both information and links to areas on the web concerning healthcare and ... www.druginfonet.com Mama
19. List of Pharmaceutical Companies at Pharmaceutical Industry's ... - With an expanding directory of pharmaceutical companies and a focus on building an online community, we are a site you don't want to miss. www.pharmaceutical-industry.info Mama
20. Pharmaceutical Marketing- Principles, Environment, and Practice

    Pharmaceutical Marketing

    Principles, Environment, and Practice:
    • Book
21. Krka Pharmaceuticals - Makers of pharmaceuticals, cosmetics, and other OTC products. www.krka.si Mama
22. Centerwatch Search - [QuickSearch]Create? You ... www.centerwatch.com Mama
23. Endo Pharmaceuticals - a specialty pharmaceutical company with market leadership... - We research, develop and market prescription pharmaceuticals used ... Privacy/Legal. © 2005 Endo Pharmaceuticals All Rights Reserved. ... www.endo.com Mama
24. Pharmaceuticals Forums - ... or try our Advanced Search Pharmaceuticals Forum Start a [NewPharmaceuticals]Create? Forums News Front Page Forums ... www.topix.net Mama
25. Forest Pharmaceuticals Recalls Levothroid Levothyroxine Thyroid Drug - Forest Pharmaceuticals has recalled the levothyroxine thyroid drug Levothroid due to subpotency prior to expiration date, information from Thyroid Patient Advocate Mary Shomon thyroid.about.com Mama
26. Welcome to Roche - The Roche Pharmaceuticals Division seeks to harness the best available internal and external resources to discover, develop, produce and ... www.roche.com Mama
27. King Pharmaceuticals Has Recalled Levoxyl - King Pharmaceuticals Has Recalled Levoxyl thyroid.about.com Mama
28. Novartis Pharma - Novartis Pharmaceuticals - Here you'll find expert information about diseases, treatments and the full Novartis US product line, and an inside look at where we're headed. ") www.pharma.us.novartis.com Mama
29. SAS Programming in the Pharmaceutical Industry

    SAS Programming in the Pharmaceutical Industry

• Book by Jack Shostak.

The Generic Challenge- Understanding Patents, Fda And Pharmaceutical Life-cycle Management

The Generic Challenge

Understanding Patents, Fda And Pharmaceutical Life-cycle Management:

• Review:: 'An Introduction for Everyone in the Pharmaceutical Business I read the Generic Challenge in one evening. It is easy to read, anecdotal and short (100 pages). My favorite portions of the book were Chapter 2 (pharmaceutical patenting strategy) and Chapter 7 (drug life-cycle management). It is hard to believe that so much information and seasoned advice is packed into this little book. Generic Challenge is not written as a reference for experts. Rather, the book is written as an introduction for readers who are new to the field and interested in the topic. Because patents are now so fundamental to the business of pharmaceuticals and biotechnology, I would recommend this book to virtually everyone working in those industries regardless of whether you will deal directly with patents.
• Review:: 'Excellent primer on intersection of patents and drug regulation The book is concise, witty, understandable by lay and law people alike, and helpful in understanding the difficulties that innovative drug companies face as well as how generics keep the innovators on their toes. Not designed as a treatise (thankfully), it is helpful for someone who wants a quick and readable overview of patents and drug laws and regulations in the U.S. and elsewhere, and how they affect the incentives to develop new drugs. This is well-suited for people who work at drug companies (whether innovator or generic) and among the professionals that serve those companies, not to mention politicians and others who make or influence policy, or anyone who wants to be informed about the facts and policies that underlie the "generic" debate that plays out in the press.
• Review:: 'Aleatory in form and content. Pages 1-40 disclose some background information relating to patents. Here, the author is plainly uncomfortable with the topic. Pages 41-107 describe various regulations relating to FDA submissions. Here, the writing is somewhat more assured. On page 14, the author states that "claims tend to get long winded because for some reason lost in the mists of time, there can only be one sentence in each claim, so that [sic] sentence sometimes gets very long." This is false. A basis for single sentence claims is the Patent Act of 1836, but also in a publication from July 1836 called "Information to Persons Having Business to Transact at the Patent Office." On page 15, the author states that the Seaborg claim is a broad claim. This is false. The Seaborg claim is a species claim (a narrow claim). The Seaborg claim is NOT a genus claim (genus claims are broad claims). On page 15, the author states that "the broadest patents have the shortest claims." This is not really true. The author forgets that certain extra words, such as "comprising" or "or", are universally used to broaden claims. Again, the author might have described how "comprising language" is used to broaden claims. The author also might have explained how "or language" is used to broaden claims. But nothing is said about these techniques for broadening claims. Note also that what can be broad is a CLAIM in a patent, not the patent itself. From the writing, the reader might infer that the SPECIFICATION determines whether a patent's coverage is broad or narrow. But this is not the case. An author writing for a novice audience should not be using careless phraseology in referring to established, clearly defined concepts. On page 16, the author tries to describe the Doctrine of Inherency, giving the example of a mechanism of action of a drug. This is a confusing example, because there are really two issues going on in this example: (1) Inherency; and (2) Failure to satisfy the utility requirement (35 USC 101). This is also a bad example because often, when faced with a discovery relating only to mechanisms, the patent attorney might draft a claim reading, "A method to detect this mechanism" or "A method to stimulate this mechanism." For the claim given by the author, when written by an attorney to read "A method to detect this mechanism" or "A method to stimulate this mechanism," only utility is an issue (inherency would no longer be an issue). The author should have used the much better example found in a case from the Federal Circuit, In re Cruciferous Sprouts. On pages 18-19, the author attempts to explain novelty, utility, and non-obviousness. However, the author only mentions the statute 35 USC 103, and fails to mention 35 USC 102 (novelty) or 35 USC 101 (utility). At this point, it is becoming clear that the "book" is unusually disorganized and inaccurate. On page 23, the author states that "A patent is a sword, not a shield. . ." This is false. As soon as a patent is filed, it becomes a powerful shield, as it can become prior art under 35 USC 102(e), preventing the allowance of U.S. patents, e.g., of competitors. Morever, as soon as a patent application is published, it also becomes a shield, preventing the allowance European patents, e.g., of a competitor. On page 28, the author tries to explain the "Function, Way, Result" test. But what a mess the author has made. The author writes, ". . . it might infringe under the doctrine of equivalents because your gizmo has an element that performs a similar function by similar means in a similar way . . ." What happened to "Result"? Where is "Result"? Where? The author is further confused here, because he uses the term "means." In patent law, the term "means" is used to invoke 35 USC 112, paragraph six. The term "means" should not be used when initiating an explanation of the Doctine of Equivalents. Another mess. On page 31, the author writes, "This is called prosecution history estoppel if you really wanted to know." This type of comment is excessively informal, and is not appropriate for a "book" on patent law. On page 89, the author states that "The FDA recently approved a combination of two well-known cholesterol lowering statins giving new life to Merck's Zocor by combining it with a newer statin sold by Schering-Plough." This is false. The compound of Schering-Plough is Zetia. But Zetia (Ezetimibe) is not a statin. This "book" contains only about 30,000 words. This is the length of a typical law review article. At $25.00, this tiny "book" is no bargain. The production could be better. While the quality of the glossy cover is excellent, the ink in my copy of the book is smeared on pages 34, 49, 88, 105, and 108. Citations for cases, and the names of cases, are missing (pages 51, 66, 71, 74). This "book" contains way too many errors in its attempts to describe various issues in patent law. For this reason, this "book" deserves zero stars.

• Similar books:
• Drugs-From Discovery to Approval
• Patents for Chemicals, Pharmaceuticals and Biotechnology- Fundamentals of Global Law, Practice and Strategy
• Inside the FDA- The Business and Politics Behind the Drugs We Take and the Food We Eat
• Pharmaceutical Patent Law
• Generic Drug Development (Drugs and the Pharmaceutical Sciences- a Series of Textbooks and Monographs)

Pharmaceutical Calculations

Pharmaceutical Calculations

Now in a new Fourth Edition that incorporates the most recent changes in pharmacy practice, Dr. Zatz's Pharmaceutical Calculations presents a logical, programmed format that builds mastery of important concepts and techniques quickly and efficiently. Used successfully by pharmacy students and professionals for over twenty years, this classic text encourages an active learning approach to tackling and solving calculation problems.

This Fourth Edition features the most up-to-date coverage available today, including:

• New concepts introduced sequentially, encouraging mastery of each concept before moving to the next
• Specific learning objectives and review questions that measure progress in each chapter
• An emphasis on dimensional analysis and direct approaches to problem solving
• Problems and solutions that reflect professional accuracy requirements
• New chapters on isotonicity, intravenous fluids, and nutritional calculations

Pharmaceutical Calculations, Fourth Edition reflects the clinical emphasis today's pharmaceutical education requires and effectively teaches how to do the computations required in current practice. This clear, comprehensive resource presents a highly practical description of pharmaceutical calculations that focuses on day-to-day professional needs. It is an ideal primary text for students of pharmacy as well as an invaluable reference for professionals.

• Review:: 'ablanco@linuxbr.com.br Good Boo

• Similar books:
• Applied Biopharmaceutics & Pharmacokinetics
• Pharmacotherapy (Pharmacotherapy)
• Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems
• Goodman & Gilman's The Pharmacological Basis of Therapeutics (Goodman and Gilman's the Pharmacological Basis of Therapeutics)
• Handbook of Nonprescription Drugs